Imaginab, Inc.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2017 | $8 M | No. 4 | $2 to $10 million | equity | SEC | |
| Mar 2016 | $5 M | No. 3 | $2 to $10 million | equity | SEC | |
| May 2014 | $16 M | No. 2 | $10 to $50 million | equity | SEC | |
| Mar 2012 | $7 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Imaginab, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2017).
SEC Form D · Sep 2017
The industry group it chose in its notices: Biotechnology.
SEC Form D · Sep 2017
That is all the official record says: Imaginab, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Imaginab, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 6 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jeffrey D. Quan | Executive officer | Sep 2017 |
| Martyn Coombs | Executive officer | Sep 2017 |
| Anna M. Wu | Executive officer | Apr 2016 |
| Benjamin Chen | Executive officer | Apr 2016 |
| Christian Behrenbruch | Chief Executive Officer | Jul 2014 |
| Jennifer D. Keppler | President and Chief Operating Officer | Jul 2014 |
| Jennifer W. Keppler | Executive officer | Apr 2012 |
| Anna W. Work | Director | Sep 2017 |
| Jeff Leonard Bailey | Director | Sep 2017 |
| Joseph Leonard Limber | Director | Sep 2017 |
| K. Leonard Judson | Director | Sep 2017 |
| Martyn Coombs | Director | Sep 2017 |
| Thilo Leonard Schroeder | Director | Sep 2017 |
| Abbie D. Celniker | Director | Apr 2016 |
| Anna M. Wu | Director | Apr 2016 |
| Campbell D. Murray | Director | Apr 2016 |
| Isaac Leonard Bright | Director | Apr 2016 |
| Abbie W. Celniker | Director | Jul 2014 |
| Campbell W. Murray | Director | Jul 2014 |
| Christian Behrenbruch | Chief Executive Officer | Jul 2014 |
| Valerie W. Calenda | Director | Jul 2014 |
| Richard W. Ding | Director | Apr 2012 |